It’s not that issues in pharmacy haven’t progressed—they have: APhA met with the Federal Trade Commission on vertical mergers; states continue their journeys toward provider status; advocacy against DIR fees continues; and as far as we know at the time of writing, oral arguments for the PBM case at the Supreme Court, Rutledge v Pharmaceutical Care Management Association, will be heard soon in a case that could change the way PBMs do business.
Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA, EVP and CEO